CMA1 and neoplasm: Such investigations may help to determine whether the decline in Chymase-positive mast cells is linked to the loss of their immunosuppressive activity at later stages of the disease and could potentially inform the development of personalized therapeutic strategies targeting the tumor microenvironment.